▶ 調査レポート

世界のIBS-C薬品市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global IBS-C Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のIBS-C薬品市場 2021:企業別、地域別、種類・用途別 / Global IBS-C Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-111D11552資料のイメージです。• レポートコード:GIR-111D11552
• 出版社/出版日:GlobalInfoResearch / 2021年10月
• レポート形態:英文、PDF、77ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥469,800 (USD3,480)▷ お問い合わせ
  Multi User¥704,700 (USD5,220)▷ お問い合わせ
  Corporate User¥939,600 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、IBS-C薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。IBS-C薬品の種類別市場規模(アミティザ、ラクツロース、マグネシアミルク、リンゼス(リナクロチド)、その他)、用途別市場規模(病院薬局、小売薬局、オンライン薬局)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・IBS-C薬品の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Allergan、Takeda、Sucampo Pharmaceuticals、IM HealthScience
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:アミティザ、ラクツロース、マグネシアミルク、リンゼス(リナクロチド)、その他
・用途別分析2016年-2026年:病院薬局、小売薬局、オンライン薬局
・IBS-C薬品の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・IBS-C薬品のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・IBS-C薬品のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・IBS-C薬品の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・IBS-C薬品の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The IBS-C Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global IBS-C Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global IBS-C Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
IBS-C Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Amitiza
Lactulose
Milk of Magnesia
LINZESS (Linaclotide)
Others

Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

The key market players for global IBS-C Drug market are listed below:
Allergan
Takeda
Sucampo Pharmaceuticals
IM HealthScience

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe IBS-C Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of IBS-C Drug, with price, sales, revenue and global market share of IBS-C Drug from 2019 to 2021.
Chapter 3, the IBS-C Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IBS-C Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and IBS-C Drug market forecast, by regions, type and distribution channel, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe IBS-C Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 IBS-C Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global IBS-C Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Amitiza
1.2.3 Lactulose
1.2.4 Milk of Magnesia
1.2.5 LINZESS (Linaclotide)
1.2.6 Others
1.3 Market Analysis by Distribution Channel
1.3.1 Overview: Global IBS-C Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global IBS-C Drug Market Size & Forecast
1.4.1 Global IBS-C Drug Sales in Value (2016-2026))
1.4.2 Global IBS-C Drug Sales in Volume (2016-2026)
1.4.3 Global IBS-C Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global IBS-C Drug Production Capacity Analysis
1.5.1 Global IBS-C Drug Total Production Capacity (2016-2026)
1.5.2 Global IBS-C Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 IBS-C Drug Market Drivers
1.6.2 IBS-C Drug Market Restraints
1.6.3 IBS-C Drug Trends Analysis
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan IBS-C Drug Product and Services
2.1.4 Allergan IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda IBS-C Drug Product and Services
2.2.4 Takeda IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sucampo Pharmaceuticals
2.3.1 Sucampo Pharmaceuticals Details
2.3.2 Sucampo Pharmaceuticals Major Business
2.3.3 Sucampo Pharmaceuticals IBS-C Drug Product and Services
2.3.4 Sucampo Pharmaceuticals IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 IM HealthScience
2.4.1 IM HealthScience Details
2.4.2 IM HealthScience Major Business
2.4.3 IM HealthScience IBS-C Drug Product and Services
2.4.4 IM HealthScience IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 IBS-C Drug Sales by Manufacturer
3.1 Global IBS-C Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global IBS-C Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in IBS-C Drug
3.4 Market Concentration Rate
3.4.1 Top 3 IBS-C Drug Manufacturer Market Share
3.4.2 Top 6 IBS-C Drug Manufacturer Market Share
3.5 Global IBS-C Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and IBS-C Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global IBS-C Drug Market Size by Region
4.1.1 Global IBS-C Drug Sales in Volume by Region (2016-2026)
4.1.2 Global IBS-C Drug Revenue by Region (2016-2026)
4.2 North America IBS-C Drug Revenue (2016-2026)
4.3 Europe IBS-C Drug Revenue (2016-2026)
4.4 Asia-Pacific IBS-C Drug Revenue (2016-2026)
4.5 South America IBS-C Drug Revenue (2016-2026)
4.6 Middle East and Africa IBS-C Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global IBS-C Drug Sales in Volume by Type (2016-2026)
5.2 Global IBS-C Drug Revenue by Type (2016-2026)
5.3 Global IBS-C Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global IBS-C Drug Sales in Volume by Application (2016-2026)
6.2 Global IBS-C Drug Revenue by Application (2016-2026)
6.3 Global IBS-C Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America IBS-C Drug Sales by Type (2016-2026)
7.2 North America IBS-C Drug Sales by Application (2016-2026)
7.3 North America IBS-C Drug Market Size by Country
7.3.1 North America IBS-C Drug Sales in Volume by Country (2016-2026)
7.3.2 North America IBS-C Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe IBS-C Drug Sales by Type (2016-2026)
8.2 Europe IBS-C Drug Sales by Application (2016-2026)
8.3 Europe IBS-C Drug Market Size by Country
8.3.1 Europe IBS-C Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe IBS-C Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific IBS-C Drug Sales by Type (2016-2026)
9.2 Asia-Pacific IBS-C Drug Sales by Application (2016-2026)
9.3 Asia-Pacific IBS-C Drug Market Size by Region
9.3.1 Asia-Pacific IBS-C Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific IBS-C Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America IBS-C Drug Sales by Type (2016-2026)
10.2 South America IBS-C Drug Sales by Application (2016-2026)
10.3 South America IBS-C Drug Market Size by Country
10.3.1 South America IBS-C Drug Sales in Volume by Country (2016-2026)
10.3.2 South America IBS-C Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa IBS-C Drug Sales by Type (2016-2026)
11.2 Middle East & Africa IBS-C Drug Sales by Application (2016-2026)
11.3 Middle East & Africa IBS-C Drug Market Size by Country
11.3.1 Middle East & Africa IBS-C Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa IBS-C Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 IBS-C Drug Typical Distributors
12.3 IBS-C Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global IBS-C Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global IBS-C Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Major Business
Table 5. Allergan IBS-C Drug Product and Services
Table 6. Allergan IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Takeda Basic Information, Manufacturing Base and Competitors
Table 8. Takeda Major Business
Table 9. Takeda IBS-C Drug Product and Services
Table 10. Takeda IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Sucampo Pharmaceuticals Major Business
Table 13. Sucampo Pharmaceuticals IBS-C Drug Product and Services
Table 14. Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. IM HealthScience Basic Information, Manufacturing Base and Competitors
Table 16. IM HealthScience Major Business
Table 17. IM HealthScience IBS-C Drug Product and Services
Table 18. IM HealthScience IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global IBS-C Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 20. Global IBS-C Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in IBS-C Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global IBS-C Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and IBS-C Drug Production Site of Key Manufacturer
Table 24. IBS-C Drug New Entrant and Capacity Expansion Plans
Table 25. IBS-C Drug Mergers & Acquisitions in the Past Five Years
Table 26. Global IBS-C Drug Sales by Region (2016-2021e) & (K Units)
Table 27. Global IBS-C Drug Sales by Region (2021-2026) & (K Units)
Table 28. Global IBS-C Drug Revenue by Region (2016-2021e) & (USD Million)
Table 29. Global IBS-C Drug Revenue by Region (2021-2026) & (USD Million)
Table 30. Global IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 31. Global IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 32. Global IBS-C Drug Revenue by Type (2016-2021e) & (USD Million)
Table 33. Global IBS-C Drug Revenue by Type (2021-2026) & (USD Million)
Table 34. Global IBS-C Drug Price by Type (2016-2021e) & (USD/Unit)
Table 35. Global IBS-C Drug Price by Type (2021-2026) & (USD/Unit)
Table 36. Global IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 37. Global IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 38. Global IBS-C Drug Revenue by Application (2016-2021e) & (USD Million)
Table 39. Global IBS-C Drug Revenue by Application (2021-2026) & (USD Million)
Table 40. Global IBS-C Drug Price by Application (2016-2021e) & (USD/Unit)
Table 41. Global IBS-C Drug Price by Application (2021-2026) & (USD/Unit)
Table 42. North America IBS-C Drug Sales by Country (2016-2021e) & (K Units)
Table 43. North America IBS-C Drug Sales by Country (2021-2026) & (K Units)
Table 44. North America IBS-C Drug Revenue by Country (2016-2021e) & (USD Million)
Table 45. North America IBS-C Drug Revenue by Country (2021-2026) & (USD Million)
Table 46. North America IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 47. North America IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 48. North America IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 49. North America IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 50. Europe IBS-C Drug Sales by Country (2016-2021e) & (K Units)
Table 51. Europe IBS-C Drug Sales by Country (2021-2026) & (K Units)
Table 52. Europe IBS-C Drug Revenue by Country (2016-2021e) & (USD Million)
Table 53. Europe IBS-C Drug Revenue by Country (2021-2026) & (USD Million)
Table 54. Europe IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 55. Europe IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 56. Europe IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 57. Europe IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 58. Asia-Pacific IBS-C Drug Sales by Region (2016-2021e) & (K Units)
Table 59. Asia-Pacific IBS-C Drug Sales by Region (2021-2026) & (K Units)
Table 60. Asia-Pacific IBS-C Drug Revenue by Region (2016-2021e) & (USD Million)
Table 61. Asia-Pacific IBS-C Drug Revenue by Region (2021-2026) & (USD Million)
Table 62. Asia-Pacific IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 63. Asia-Pacific IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 64. Asia-Pacific IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 65. Asia-Pacific IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 66. South America IBS-C Drug Sales by Country (2016-2021e) & (K Units)
Table 67. South America IBS-C Drug Sales by Country (2021-2026) & (K Units)
Table 68. South America IBS-C Drug Revenue by Country (2016-2021e) & (USD Million)
Table 69. South America IBS-C Drug Revenue by Country (2021-2026) & (USD Million)
Table 70. South America IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 71. South America IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 72. South America IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 73. South America IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 74. Middle East & Africa IBS-C Drug Sales by Country (2016-2021e) & (K Units)
Table 75. Middle East & Africa IBS-C Drug Sales by Country (2021-2026) & (K Units)
Table 76. Middle East & Africa IBS-C Drug Revenue by Country (2016-2021e) & (USD Million)
Table 77. Middle East & Africa IBS-C Drug Revenue by Country (2021-2026) & (USD Million)
Table 78. Middle East & Africa IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 79. Middle East & Africa IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 80. Middle East & Africa IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 81. Middle East & Africa IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 82. Direct Channel Pros & Cons
Table 83. Indirect Channel Pros & Cons
Table 84. IBS-C Drug Typical Distributors
Table 85. IBS-C Drug Typical Customers
List of Figures
Figure 1. IBS-C Drug Picture
Figure 2. Global IBS-C Drug Sales Market Share by Type in 2020
Figure 3. Amitiza
Figure 4. Lactulose
Figure 5. Milk of Magnesia
Figure 6. LINZESS (Linaclotide)
Figure 7. Others
Figure 8. Global IBS-C Drug Sales Market Share by Application in 2020
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global IBS-C Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global IBS-C Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global IBS-C Drug Sales (2016-2026) & (K Units)
Figure 15. Global IBS-C Drug Price by Type (2016-2026) & (USD/Unit)
Figure 16. Global IBS-C Drug Production Capacity (2016-2026) & (K Units)
Figure 17. Global IBS-C Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. IBS-C Drug Market Drivers
Figure 19. IBS-C Drug Market Restraints
Figure 20. IBS-C Drug Market Trends
Figure 21. Global IBS-C Drug Sales Market Share by Manufacturer in 2020
Figure 22. Global IBS-C Drug Revenue Market Share by Manufacturer in 2020
Figure 23. IBS-C Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 IBS-C Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 IBS-C Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Global IBS-C Drug Sales Market Share by Region (2016-2026)
Figure 27. Global IBS-C Drug Revenue Market Share by Region (2016-2026)
Figure 28. North America IBS-C Drug Revenue (2016-2026) & (USD Million)
Figure 29. Europe IBS-C Drug Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific IBS-C Drug Revenue (2016-2026) & (USD Million)
Figure 31. South America IBS-C Drug Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa IBS-C Drug Revenue (2016-2026) & (USD Million)
Figure 33. Global IBS-C Drug Sales Market Share by Type (2016-2026)
Figure 34. Global IBS-C Drug Revenue Market Share by Type (2016-2026)
Figure 35. Global IBS-C Drug Price by Type (2016-2026) & (USD/Unit)
Figure 36. Global IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 37. Global IBS-C Drug Revenue Market Share by Application (2016-2026)
Figure 38. Global IBS-C Drug Price by Application (2016-2026) & (USD/Unit)
Figure 39. North America IBS-C Drug Sales Market Share by Type (2016-2026)
Figure 40. North America IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 41. North America IBS-C Drug Sales Market Share by Country (2016-2026)
Figure 42. North America IBS-C Drug Revenue Market Share by Country (2016-2026)
Figure 43. United States IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe IBS-C Drug Sales Market Share by Type (2016-2026)
Figure 47. Europe IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 48. Europe IBS-C Drug Sales Market Share by Country (2016-2026)
Figure 49. Europe IBS-C Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific IBS-C Drug Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific IBS-C Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific IBS-C Drug Revenue Market Share by Region (2016-2026)
Figure 59. China IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America IBS-C Drug Sales Market Share by Type (2016-2026)
Figure 66. South America IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 67. South America IBS-C Drug Sales Market Share by Country (2016-2026)
Figure 68. South America IBS-C Drug Revenue Market Share by Country (2016-2026)
Figure 69. Brazil IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa IBS-C Drug Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa IBS-C Drug Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa IBS-C Drug Revenue Market Share by Country (2016-2026)
Figure 75. Turkey IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source